Strategies for targeting residual HIV infection.
aCentre de Recherche du CHUMbDepartment of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Quebec, CanadacDivision of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Nicolas
N
Chomont
Matthieu
M
Perreau
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D000072230:Sustained Virologic Response; D016896:Treatment Outcome; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents